Credit Suisse is out with a research report on IBM IBM and is lowering estimates on the Armonk, N.Y.-based company. It has a Neutral rating and a $175 price target on shares.
In a note to clients, Credit Suisse writes, "We update our CY11/CY12 EPS estimates from $13.29/$14.77 to $13.23/$14.65 given building macro headwinds. The Public and Financial verticals, which represent 45% of sales, have exhibited weakness. Relative to other enterprise players, IBM has superior execution, services exposure and levers to protect its earnings, making it defensive near term."
Shares of IBM closed at $172.51 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in